<DOC>
	<DOCNO>NCT01548222</DOCNO>
	<brief_summary>This trial determine patient well control basal insulin treat excessive basal dose .</brief_summary>
	<brief_title>CGM Evaluation Glucose Excursions Basal Insulin Treated T2DM Fasting Glucose Target</brief_title>
	<detailed_description>In many clinical trial , basal insulin titrate fast glucose goal . The usual final dose &gt; 0.4U/kg . In carefully CGM monitored/titrated study basal insulin alone pump-treated T2DM , find basal insulin dose &lt; 0.3U/kg . This suggest guide single daily fast glucose , titration may result excessive basal dose . This study examine issue .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Type 2 diabetes Age 18 year Concurrently +/thiazolidnedione +/DDP IV inhibitor +/metformin +/ glinides basal insulin analog A1C 10 % Capable self monitor glucose least 4 x day Previously compliant clinical recommendation Fasting blood glucose &lt; 110mg/dl average 3 consecutive day BMI &lt; 45 kg/m Urinary ketosis Current expect alternation insulin sensitivity major surgery , infection , renal failure , glucocorticoid treatment , recent serious hypoglycaemic episode Currently participate another clinical trial Using rapid insulin insulin Pregnancy nursing intention become pregnant use adequate birth control Significant liver heart failure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>type 2 diabetes</keyword>
	<keyword>continuous glucose</keyword>
	<keyword>basal insulin</keyword>
</DOC>